All Posts Tagged With: "CVS"

(WAG) Walgreen and AmerisourceBergen Get Green Light for Deal

The largest retail pharmacy chain in the U.S., Walgreen Co. (WAG) and Alliance Boots continue to make steady progress to boost their global presence in the prescription drug purchasing space. The regulatory approval for the companies’...

12Aug2013 | | Comments Off | Continued

(WAG) Walgreens Reaches New 52-Week High

Shares of Walgreen Co. (WAG) touched a new 52-week high of $50.50 on Wednesday, May 15, 2013 following strong annual results of Alliance Boots GmbH. Walgreens has a 45% equity ownership stake in the European pharmacy-led, health and...

23May2013 | | Comments Off | Continued

(WAG) Still Neutral on Walgreens

On Apr 17, we reaffirmed our long-term Neutral recommendation on Walgreen Co. (WAG) following the mixed second-quarter fiscal 2013 results. While the last quarter results reflect a definite improvement over the past few quarters, the...

2May2013 | | Comments Off | Continued

(RAD) Rite Aid Hits 52-Week High

Following better-than-expected fourth-quarter fiscal 2013 results and an impressive fiscal 2014 outlook, shares of Rite Aid Corp. (RAD) attained a new 52-week high of $2.33 on Friday, Apr 12, before closing at $2.31. This Zacks Rank...

21Apr2013 | | Comments Off | Continued

(CAH) Cardinal Health Completes Takeover

Leading distributor of pharmaceuticals and medical supplies Cardinal Health (CAH) recently revealed that it has accomplished the takeover of AssuraMed, a privately held provider of medical supplies for patients in the residential setting,...

4Apr2013 | | Comments Off | Continued

(MCK) McKesson Acquires PSS World Medical

McKesson Corporation (MCK) recently announced that it has completed its previously announced acquisition of PSS World Medical, Inc. McKesson paid $2.1 billion for the acquisition including PSS World Medical’s debt of...

6Mar2013 | | Comments Off | Continued

(WAG) Walgreens Earnings Preview

Walgreen Co. (WAG) is slated to release its first quarter 2013 earnings results on Friday, December 21, 2012, before the market opens. The Zacks Consensus Estimate currently stands at 67 cents per share for the quarter. This represents...

23Dec2012 | | Comments Off | Continued

(CVS) CVS Caremark Corporation Provides Impressive FY13 View

CVS Caremark Corporation (CVS), one of the largest domestic integrated pharmacy services providers, recently updated its fiscal 2013 outlook and highlighted its growth framework, while reiterating its earlier guidance for the current...

16Dec2012 | | Comments Off | Continued

(CVS) CVS Caremark Reports Mixed Third Quarter

CVS Caremark (CVS) reported third quarter 2012 earnings per share (EPS) of 79 cents, up 21.5% year over year. However, after excluding the impact of certain acquisition related expenses from both the periods, the adjusted EPS in the...

20Nov2012 | | Comments Off | Continued

(OSUR) OraSure Technologies Unveils In-Home HIV test

OraSure Technologies (OSUR), a provider of medical devices and technologies to diagnose critical medical conditions, recently announced the availability of its OraQuick in-home HIV test at retail outlets and online, across the U.S. The...

23Oct2012 | | Comments Off | Continued

(BRKA) Form 13F: A “Cheat Sheet” for Uncovering the Best Stocks in the Market

Your level of success as an investor typically boils down to how well you can do one thing – analyze business fundamentals. That’s because, regardless of what the economy and the stock market are doing, companies that are increasing sales, compounding earnings at high rates, growing market...

26Aug2012 | | 0 comments | Continued

(BIOS) BioScrip Analyst Remains Neutral on Shares

We are maintaining our Neutral recommendation on BioScrip Inc. (BIOS) with a target price of $8.00. BioScrip reported a loss of 7 cents per share from continued operations in the second quarter of fiscal 2012, wider than last...

26Aug2012 | | Comments Off | Continued

(CVS) CVS Caremark Corporation Shares Remain at Neutral

We have reiterated our Neutral recommendation on CVS Caremark Corporation (CVS) with a target price of $47.00. CVS Caremark’s second quarter adjusted earnings per share (EPS) increased 14.0% year over year to 81cents, beating...

21Aug2012 | | Comments Off | Continued

(HNT) Health Net Lags – Lowers Guidance

Health Net Inc.’s (HNT) second-quarter 2012 operating income, which includes combined net earnings from Western Region and Government Contracts segments, came in at $15.9 million or 19 cents per share, declining substantially from...

6Aug2012 | | Comments Off | Continued

(AET) Aetna Analyst Reiterates Shares at Neutral

We are reiterating our Neutral recommendation on the shares of Aetna Inc. (AET) prior to its second quarter earnings release scheduled on July 31, 2012, before the opening bell.  The Zacks Consensus Estimate of earnings is pegged...

16Jul2012 | | Comments Off | Continued

(PBM) Catalyst Health Solutions Acquired by SXC Health Solutions

On Monday, Catalyst Health Solutions Inc. was acquired by rival pharmacy benefits management (PBM) company, SXC Health Solutions Corp. (SXCI). Subsequently, Catalyst Health was de-listed from the New York Stock Exchange, on which...

8Jul2012 | | Comments Off | Continued

(HUM) Attention Shifts to Jobs – Earnings Preview

Earnings Preview – Week of April 30th The focus this week will be on the labor market, with the April non-farm payroll report coming out on Friday. Many will be hoping that this report will provide confirmation that last month’s...

28Apr2012 | | Comments Off | Continued

(CHSI) SXC Health Solutions to Buy Catalyst Health

On Wednesday, Catalyst Health Solutions Inc. (CHSI) announced that it has entered into a $4.4 billion takeover agreement with rival pharmacy benefits management (PBM) company, SXC Health Solutions Corp. (SXCI)....

21Apr2012 | | Comments Off | Continued

(CVS) Management Churn at CVS Caremark

CVS Caremark Corporation (CVS) recently announced a change in top management. According to the company’s design, effective September 1, 2012, the present EVP and Chief Operating Officer of the Pharmacy Benefit Management (PBM) business,...

4Apr2012 | | Comments Off | Continued

(MHS) Medco Healh Analyst Reiterates Shares at Neutral

Recently, we reiterated our Neutral recommendation on Medco Health (MHS) with a target price of $74.00. During the fourth quarter of fiscal 2011, Medco reported adjusted EPS of $1.25, beating the Zacks Consensus Estimate of...

22Mar2012 | | Comments Off | Continued

(CVS) CVS Caremark Remains Neutral

Recently, we reiterated our Neutral recommendation on CVS Caremark Corporation (CVS) with a target price of $46.00. CVS reported adjusted EPS of 89 cents in the fourth quarter of 2011 in line with the Zacks Consensus Estimate...

2Mar2012 | | Comments Off | Continued

(CSCO) Slow Data Week Ahead – Earnings Preview

Earnings Preview 2/3/12 Earnings season will be in full swing next week, with 507 firms scheduled to report, and 69 of those will be members of the S&P 500.  By the end of the week we will be almost three quarters done with...

7Feb2012 | | 0 comments | Continued

(CVS) CVS Caremark Corporation Ordered by FTC to Settle Claims

Recently CVS Caremark Corporation (CVS) was asked by the Federal Trade Commission (FTC) to pay $5 million to settle all claims related to the company’s misrepresentation of prices of certain Medicare Part D prescription...

13Jan2012 | | 0 comments | Continued

(WAG) Walgreens 2012 First Quarter Earnings Scorecard

Subsequent to the announcement of Walgreen’s (WAG) first quarter 2012 (ended November 30) results on December 21, 2011, majority of the analysts have reduced their estimates for the forthcoming period. Previous Quarter...

9Jan2012 | | 0 comments | Continued

(ESRX) Walgreen Braves Express Scripts Loss

The six-month dispute with Express Scripts (ESRX) took its toll on Walgreen’s (WAG) recently released first quarter fiscal 2012 results. The company’s bottom-line...

3Jan2012 | | 0 comments | Continued

(WAG) Walgreen Plans to Offset Express Scripts Loss

Walgreen (WAG) is commencing the New Year with efforts aimed at minimizing the impact of the non-renewal of the Express Scripts (ESRX) contract, which has just lapsed....

3Jan2012 | | 0 comments | Continued

(CVS) CVS Caremark Corporation to Attend Healthcare Conference

The leading provider of prescriptions and related health care services in the US, CVS Caremark Corporation (CVS) has decided to participate in the annual JP Morgan Healthcare Conference scheduled on January 10, 2012. The company will...

30Dec2011 | | 0 comments | Continued

(BRKA) Berkshire Hathaway’s Buffett Adds Hometown Newspaper

On Wednesday, Warren Buffett, the Chairman and CEO of Berkshire Hathaway Inc. (BRKA) (BRKB), announced an acquisition to buy The Omaha World-Herald Company, publisher of Nebraska’s...

2Dec2011 | | 0 comments | Continued

(SKS) U.S. Retail Still Rolling – Zacks Industry Rank Analysis

Industry Rank Analysis 11-15-11 Before you know it, Christmas will be here. That is something that tends to bring retail front and center to the minds of investors. Rumors of the death of the U.S. consumer appear to be...

18Nov2011 | | 0 comments | Continued

(CVS) CVS Caremark Launches New Pharmacy Advisor Program

CVS Caremark (CVS) recently launched a new Pharmacy Advisor program to help treat chronic cardiovascular illness. The Pharmacy Advisor for chronic cardiovascular care will primarily focus on medication adherence for persistent...

14Nov2011 | | 0 comments | Continued